Feed TMDX
TM

TransMedics

TMDX · NASDAQ

$85.29 +2.14% (+$1.79)
1M -3.55%
Market Cap $2.90B
P/E Ratio 19.11x
Div. Yield -
ROE 32.97%

Bulios Fair Price

$85.81

0.6% upside

Current Price

$85.29

Undervalued Fair Value Overvalued

According to Bulios Fair Price, TMDX is currently trading close to its fair value. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Moderate
4/9
Valuation
37 /100
Fair
P/FCF 36.69x
P/S 4.34x
P/B 5.60x
Growth
100 /100
Growing
Book val. growth 36.17%
Rev. growth 86.42%
FCF growth N/A
Profitability
78 /100
Strong
Net margin 22.69%
Op. margin 12.21%
FCF margin 11.82%
Quality
76 /100
Excellent
ROE 32.97%
ROA 10.36%
Asset turnover 0.46x
Debt
47 /100
Moderate
Current ratio 6.62x
Int. coverage 4.42x
Net debt/EBITDA 3.29x
Stability
6 /100
Unstable
Rev. volatility 61.32%
EPS volatility 172.83%
Profitable years 2

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about TMDX
Online

About the company

TransMedics Group, Inc. (TMDX) is an American company specializing in the development and manufacturing of innovative medical devices for organ transplantation. With the aim of improving the preservation and transportation of organs intended for transplantation, TransMedics has developed the Organ Care System (OCS) technology. This technology allows organs to be maintained in optimal condition during transportation, potentially increasing the success of transplant procedures. The company is known for its commitment to saving lives and innovations in the field of organ transplantation. TransMedics Group, Inc. (TMDX) shares could be suitable for investors looking to invest in a company actively supporting medical research and life-saving through organ transplantation.

Sector

Healthcare

Industry

Medical - Devices

CEO

Waleed H. Hassanein

Employees

898

Headquarters

Andover

Upcoming events

04 NOV

Earnings

Upcoming earnings report

38d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.